Our Elmiron Lawyers Are Fighting for Clients Nationwide
Attention, consumers: the bladder pain drug Elmiron causes vision problems, eye disorders, and blindness in many users. Even short-term use of Elmiron can cause grave problems for patients.
Recently, the Food and Drug Administration also approved a label change for the drug, outlining risks and side effects so that users are warned about the dangers of taking Elmiron. This, however, is not enough to protect patients from a drug as harmful as Elmiron.
Medicines are thought to bring healing. We think of pills as taking away our pain, driving away illness and restoring us to good health.
But prescription medications may have terrible side effects, even causing dangerous diseases and death. Research shows that new prescription drugs have a 1 in 5 chance of causing severe reactions even after they have been approved by the FDA. Even drugs that have been prescribed properly lead to around 1.9 million hospitalizations every year.
Prescription drugs are the fourth leading cause of death in the United States. But the growing clout of pharmaceutical companies and the lobbying power of Big Pharma is ensuring that dangerous drugs continue to enter the market, without warnings about their toxicity and side effects.
Elmiron is one such drug—it was approved by the FDA to treat painful bladder conditions, but causes vision loss and blindness.
If you have been injured by taking Elmiron, talk to one of the lawyers at Pintas & Mullins today. We handle drug injury cases nationwide and can help discuss your legal options.
For a free legal consultation with a elmiron lawyer serving nationwide, call (800) 794-0444
Elmiron Causes Vision Loss
Elmiron (pentosan polysulfate sodium) is a blood thinning drug or anti-coagulant manufactured by Janssen Pharmaceuticals, Inc, a subsidiary of Johnson & Johnson. Elmiron is prescribed to prevent blood clots, reduce bladder pain and inflammation, and treat interstitial cystitis (IC). IC is a painful urinary tract condition affecting millions of Americans, and Elmiron is the only FDA-approved drug to treat it. This means that patients with IC might not be able to obtain an alternative for their pain.
Recently, Elmiron has been linked to eye disorders, especially a unique form of progressive eye disease called retinal maculopathy, or other retinal disorders which might result in blindness.
Patients who have taken Elmiron have reported the following symptoms:
- Vision loss
- Blind spots
- Distorted vision
- Blurred vision
- Difficulty reading
- Difficulty adapting to dim light
- Dark spots in vision
- Less bright colors
A study of patients in Northern California found that a quarter of patients exposed to Elmiron showed eye damage.
Conditions which may be associated with Elmiron use include:
- Pigmentary maculopathy
- Pigmentary macular degeneration
- Pigmentary maculitis
- Pentosan polysulfate sodium (PPS) maculopathy
- Retinal problems
- Dry macular degeneration
If you have used Elmiron and are now suffering from any eye disorder, you deserve to be compensated for your pain. The drug injury lawyers at Pintas & Mullins have counselled many clients in drug-related cases and can give expert legal advice and guidance for your case.
Elmiron Lawyer Near Me (800) 794-0444
FDA Approves Warning Label for Elmiron
On June 16, 2020, the FDA approved a changed label for Elmiron warning of the drug’s dangerous side effects. The drug’s manufacturer, Janssen Pharmaceutical Companies, revised the label to include “Retinal Pigmentary Changes” under the “Warnings” section.
This change, however, comes too late. The manufacturers included similar warnings in Canada in October, 2019 and in Europe as early as June 2019. They took much longer to warn the American public about the risks associated with even short-term use of Elmiron.
Before the label was changed, Janssen and its parent company Johnson & Johnson only mentioned hair loss, diarrhea, nausea, and headaches as potential side effects.
Even now, the label is not as effective as a black box warning, the most stringent FDA warning. Given the risk of permanent blindness associated with Elmiron use, even stronger measures need to be taken against the manufacturers of the drug.
Those harmed by the drug have a right to compensation for the negligence that has resulted in life-long pain and suffering.
You May Be Entitled to Significant Compensation
Janssen Pharmaceuticals had the obligation to warn Elmiron users about the drug’s potentially life-altering side effects. It failed in its duty toward consumers and must be held accountable for its careless actions.
If you have suffered because of Elmiron, reach out to our firm today. Our lawyers have expertise dealing with drug claims nationwide, and can provide you the knowledge and guidance you need. Join many others in filing claims against the company for marketing a drug like Elmiron that has damaged eyes beyond repair.